oncolytic ICI encoded MSV (Themis Bioscience)

N/A

Report date: 2025/03/20 10:06:20

Base Information

Drug Nameoncolytic ICI encoded MSV (Themis Bioscience)

Drug Alias Nameoncolytic immune checkpoint inhibitor encoded measles virus (Themis Bioscience)immune checkpoint inhibitor encoded measles virus (Themis Bioscience)

ClassificationBiologics

Mechanisms of ActionMembrane cofactor protein modulators

TargetsMembrane cofactor protein

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustria

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMax Planck Innovation

China Registration ClassN/A

Develop Information

Active CompaniesThemis Bioscience Gmbh

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A